Sign Up to like & get
recommendations!
1
Published in 2017 at "British Medical Journal"
DOI: 10.1136/bmj.j9
Abstract: The National Institute for Health and Care Excellence (NICE) said in draft guidance that it cannot recommend the advanced breast cancer drug trastuzumab emtansine (Kadcyla) for routine NHS use in England and Wales because it…
read more here.
Keywords:
medicine;
seven days;
days medicine;
medicine december ... See more keywords